Study Details

Healthy Adults, Age 18-65

Study Number

8409-184-G2

Group

Group 2

Gender

both

Age

18-65

Location

Madison, Wisconsin

Compensation

$7,658

Study Dates

Dec. 11, 2019 - Apr. 16, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

•Healthy Non-Smoking Adults age 18-65

•BMI (body mass index) 18-30

•Join us for a stay of 8 nights followed by 11 outpatient visits

•Compensation up to $7658 may be provided for time and participation

Details

Screening Dates: Dec 6, and 9

Check-In: Dec 11
Check-Out: Dec 19

Outpatient Visits:
Dec 22, 26
Jan 2, 9, 23
Feb 6, 20
Mar 5, 19
Apr 2, 16

Study Number

8409-184-G2

Group

Group 2

Gender

both

Age

18-65

Location

Madison, Wisconsin

Compensation

$7,658

Study Dates

Dec. 11, 2019 - Apr. 16, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

•Healthy Non-Smoking Adults age 18-65

•BMI (body mass index) 18-30

•Join us for a stay of 8 nights followed by 11 outpatient visits

•Compensation up to $7658 may be provided for time and participation

Details

Screening Dates: Dec 6, and 9

Check-In: Dec 11
Check-Out: Dec 19

Outpatient Visits:
Dec 22, 26
Jan 2, 9, 23
Feb 6, 20
Mar 5, 19
Apr 2, 16

Calculate Your BMI!

Calculate Your BMI!